SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Hua who wrote (1234)3/10/2000 10:29:00 AM
From: Jim Roof  Read Replies (1) of 1972
 
Tom,

Some day you will look back at this 'stock killer' story and see that not only was it a poorly researched media hype piece but that it provided a wonderful opportunity to get into VICL.

VICL will recover when it is finally figured out that this is a gross overreaction to what is, in medical terms, the cost of doing business. In fact, I am certain that there will be more unexplained deaths that an honest researcher cannot totally rule out the therapy as a contributing factor (as was true in this case) but consider the near extremely high death rate of melanoma and the very high death rate associated with other treatments. Then tell me that ONE unexplained death in 400 patients tested kills this company and its technology.

If you sold yesterday then I at least hope you waited until the afternoon.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News